BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

European Patent Office Grants Metabolon Patent for Determining Metabolic Age of an Individual


12/20/2011 6:15:08 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today the grant of EP Patent 2,089,539B entitled, “Biomarkers Related to Metabolic Age and Methods Using the Same.” The European Patent Office awarded the patent to Metabolon on December 7, 2011 and is the first patent issued to Metabolon by the EPO. The newly issued patent extends Metabolon’s intellectual property (IP) related to biomarkers of metabolic age; US7,781,160, the related United States Patent, was issued by the United States Patent and Trademark Office in August 2010.

Read at BioSpace.com

Metabolon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->